Experience

Mestrelab Research S.L.

• Spain
• Program Development
• 1 - 100 Employee

• Strategic Account Director

  • Jun 2020 - Present



NovAliX

• France
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• • Jul 2019 - Oct 2019

  ♦ Led a 20 people Insourcing group at Eli Lilly (Alcobendas, Spain)♦ Managed the daily relationship with the clients (Spain, Belgium, UK, US)♦ Designed medicinal chemistry projects (multi-step synthesis at H2L & LO stages), Organized the teams & ensured completion of the projects following the client’s technical requirements and deadline.

• • Dec 2017 - Jul 2019

  ♦ Led a team of 4-5 persons at Eli Lilly♦ Designed medicinal chemistry projects (multi-step synthesis at H2L & LO stages), Organized the teams & ensured completion of the projects following the client’s technical requirements and deadline.♦ Reported progress in the projects to the clients (Spain, UK, US).♦ Elaborated & implemented a chemistry training program for the chemistry research associates. The program has been successfully running across the sites of the Company for 5 years.♦ Participated in the recruitment process of candidates for several teams within the Company. Show less

• • Aug 2011 - Dec 2017

  ♦ Led a team of 4-5 persons in an Insourcing group at Janssen Cilag (Toledo, Spain)♦ Designed medicinal chemistry projects (multi-step synthesis at H2L & LO stages), Organized the teams & ensured completion of the projects following the client’s technical requirements and deadline.♦ Reported progress in the projects to the clients (Spain, UK, US).♦ Elaborated & implemented a chemistry training program for the chemistry research associates. The program has been successfully running across the sites of the Company for 5 years.♦ Participated in the recruitment process of candidates for several teams within the Company. Show less



Evotec (UK) Ltd

• Abindgon (Oxfordshire, UK)

• Senior Scientist

  • May 2010 - Jul 2011

  ♦ Designed & developed H2L projects (Voltage-gated K ion channels) in an outsourcing medicinal chemistry team of 8 persons. ♦ Reported progress in the projects to the client. ♦ Designed & developed H2L projects (Voltage-gated K ion channels) in an outsourcing medicinal chemistry team of 8 persons. ♦ Reported progress in the projects to the client.



Sterix Ltd

• Research Scientist

  • Jan 2003 - Sep 2010

  ♦ Designed & implemented H2L and LO projects in oncology in a medicinal chemistry team of 4 persons. ♦ Reported progress in the projects internally. ♦ A pre-clinical candidate drug was developed, and the various projects led to 4 patents and 10 publications. ♦ Designed & implemented H2L and LO projects in oncology in a medicinal chemistry team of 4 persons. ♦ Reported progress in the projects internally. ♦ A pre-clinical candidate drug was developed, and the various projects led to 4 patents and 10 publications.



John Innes Centre

• Research Scientist

  • Aug 2000 - Dec 2002

  Investigations on the Molybdenum containing enzymes (Xanthine Oxidase family) in Research Programmn of a European Network fnded by the EU ♦ Elaborated & implemented a project aiming at new potential Xanthine Oxidase inhibitors. ♦ Designed a project aiming at new DNA gyrase inhibitors as a new family of anti-cancer agents. The project was selected by the John Innes Institute that funded a Ph. D. fellowship. Investigations on the Molybdenum containing enzymes (Xanthine Oxidase family) in Research Programmn of a European Network fnded by the EU ♦ Elaborated & implemented a project aiming at new potential Xanthine Oxidase inhibitors. ♦ Designed a project aiming at new DNA gyrase inhibitors as a new family of anti-cancer agents. The project was selected by the John Innes Institute that funded a Ph. D. fellowship.



ICMIB - CNR - Naples

• postdoctoral research officer

  • Jul 1996 - Jul 2000

  In a European Network studying the class II Major Histocompatibility Complex (MHC II) ♦ Set-up of 2D and 3D NMR spectroscopy experiments for the 3D structure determination of biologically relevant peptides via Molecular Modelling. Analysed 3D structures and their biological implications. In a European Network studying the class II Major Histocompatibility Complex (MHC II) ♦ Set-up of 2D and 3D NMR spectroscopy experiments for the 3D structure determination of biologically relevant peptides via Molecular Modelling. Analysed 3D structures and their biological implications.



Hokkaido University

• Japan
• Higher Education
• 400 - 500 Employee

• Postdoctoral Scientist

  • Mar 1996 - Sep 1996

  ♦ Within the group of Pr K. Maruoka I developed the synthesis of organometallic allylating reagents. ♦ Within the group of Pr K. Maruoka I developed the synthesis of organometallic allylating reagents.